BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17178337)

  • 1. Predictors of decline in renal function after lung transplantation.
    Barraclough K; Menahem SA; Bailey M; Thomson NM
    J Heart Lung Transplant; 2006 Dec; 25(12):1431-5. PubMed ID: 17178337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
    Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of renal function in heart transplantation patients after conversion from a calcineurin inhibitor-based therapy to sirolimus.
    Ayub-Ferreira SM; Avila MS; Feitosa FS; Souza GE; Mangini S; Marcondes-Braga FG; Issa VS; Bacal F; Chizzola PR; Cruz FD; Bocchi EA
    Transplant Proc; 2010 Mar; 42(2):542-4. PubMed ID: 20304188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients.
    Potter BJ; Giannetti N; Edwardes MD; Cecere R; Cantarovich M
    Clin Transplant; 2007; 21(3):305-8. PubMed ID: 17488377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study.
    Holdaas H; Rostaing L; Serón D; Cole E; Chapman J; Fellstrøm B; Strom EH; Jardine A; Midtvedt K; Machein U; Ulbricht B; Karpov A; O'Connell PJ;
    Transplantation; 2011 Aug; 92(4):410-8. PubMed ID: 21697773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction.
    Gustafsson F; Ross HJ; Delgado MS; Bernabeo G; Delgado DH
    J Heart Lung Transplant; 2007 Oct; 26(10):998-1003. PubMed ID: 17919619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
    Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
    Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels.
    Morard I; Mentha G; Spahr L; Majno P; Hadengue A; Huber O; Morel P; Giostra E
    Clin Transplant; 2006; 20(1):96-101. PubMed ID: 16556162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease in children following lung and heart-lung transplantation.
    Benden C; Kansra S; Ridout DA; Shaw NL; Aurora P; Elliott MJ; Marks SD
    Pediatr Transplant; 2009 Feb; 13(1):104-10. PubMed ID: 19087230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of long-term renal function after conversion to proliferation signal inhibitors in long-term heart transplant recipients.
    González-Vilchez F; de Prada JA; Castrillo C; Canteli A; Llano MF; Martín-Durán R
    J Heart Lung Transplant; 2011 May; 30(5):552-7. PubMed ID: 21212001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients.
    Kaplinsky E; González-Costello J; Manito N; Roca J; Barbosa MJ; Nebot M; Salazar-Mendiguchia J; Berdejo J; Mañas P; Miralles A; Cequier A
    Transplant Proc; 2012 Nov; 44(9):2564-6. PubMed ID: 23146455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension as a marker for later development of end-stage renal failure after lung and heart-lung transplantation: a cohort study.
    Kunst H; Thompson D; Hodson M
    J Heart Lung Transplant; 2004 Oct; 23(10):1182-8. PubMed ID: 15477113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis after lung transplantation: prevalence, risk factors and outcome.
    Mason DP; Solovera-Rozas M; Feng J; Rajeswaran J; Thuita L; Murthy SC; Budev MM; Mehta AC; Haug M; McNeill AM; Pettersson GB; Blackstone EH
    J Heart Lung Transplant; 2007 Nov; 26(11):1155-62. PubMed ID: 18022082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
    Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
    Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients.
    Corman SL; Coley KC; Schonder KS
    Pharmacotherapy; 2006 Oct; 26(10):1433-7. PubMed ID: 16999653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation: impact of pretransplant renal insufficiency.
    Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
    Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation.
    Stephany BR; Augustine JJ; Krishnamurthi V; Goldfarb DA; Flechner SM; Braun WE; Hricik DE; Dennis VW; Poggio ED
    Transplantation; 2006 Aug; 82(3):368-74. PubMed ID: 16906035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.